Abstract | BACKGROUND: MATERIALS AND METHODS: RESULTS: All 16 patients completed the six-question MASCC form. Eleven of 16 had no nausea or vomiting and two other patients had only minimal nausea, despite absence of any prophylactic antiemetics. Only two patients required antiemetic support. Two patients experienced emesis for a single episode. One patient had nausea on days 9-20 with a MASCC rating of 3-6, and one patient had continued mild nausea (MASCC rating 1-3) for all 21 days. CONCLUSIONS:
|
Authors | Lawrence H Einhorn, Mary J Brames |
Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
(Support Care Cancer)
Vol. 14
Issue 12
Pg. 1262-5
(Dec 2006)
ISSN: 0941-4355 [Print] Germany |
PMID | 16896880
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents, Phytogenic
- Etoposide
|
Topics |
- Administration, Oral
- Antineoplastic Agents, Phytogenic
(adverse effects)
- Etoposide
(adverse effects)
- Humans
- Male
- Nausea
(chemically induced)
- Prospective Studies
- Vomiting
(chemically induced)
|